BioStem Technologies, Inc. Revenue Breakdown
No Revenue Breakdown for BSEM on this site yet.
- 2025-12-31: Others Not split by product in the filing$47.48M100.00%; Total revenue $47.48M.
- 2024-12-31: Others Not split by product in the filing$69.66M100.00%; Total revenue $69.66M.
Source checked: the stored Revenue Breakdown page for BSEM.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $47.48M 100.00% | $47.48M |
| 2024-12-31 | Not split by product in the filing $69.66M 100.00% | $69.66M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $7.90M 100.00% | $7.90M |
| 2025-06-30 | Not split by product $10.96M 100.00% | $10.96M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |